Skip to main content
All lobbying filings

SHIONOGI INC.

Lobbying for SHIONOGI INC. · Pharmaceutical company

 Filing 1st Quarter - Termination
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 18, 2025
Expenses
$100,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New Jersey
Representation ended
Mar 14, 2025
The registrant reported terminating its work for this client.

Official filing document

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Pharmacy

Pandemic preparedness; Antimicrobial resistance; Pandemic and All Hazards Preparendess Act (PAHPA) Reauthorizaion;

Budget/Appropriations

BARDA funding IBMSC funding Strategic National Stockpile funding

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem